Español Head lice affect millions of children every year. Schoolchildren are commonly affected by head lice, which attach to hair and feed on human blood. “Although […]

[embedded content] Español Social media trends and peer pressure can be a dangerous combination to your children and their friends, especially when involving misusing medicines.  One […]

For Immediate Release: February 21, 2025 Today, the U.S. Food and Drug Administration approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Ctexli […]

Español The U.S. Food and Drug Administration is warning consumers that the agency continues to receive adverse event reports related to selective androgen receptor modulators, commonly […]

[embedded content] Español How often has this happened to you: You pick up a prescription at the pharmacy and later realize you have questions about something […]

This listing includes accelerated approvals (AAs) for non-malignant hematological, neurological, and other disorder indications that have postmarketing requirement(s) that have been subsequently withdrawn, and are therefore, no longer FDA-approved. […]

Summary Company Announcement Date: February 20, 2025 FDA Publish Date: February 20, 2025 Product Type: Dietary SupplementsDrugs Reason for Announcement: Recall Reason Description Undeclared Sildenafil and […]

Español Drug Safety Podcast Drug Safety Communication (PDF – 52KB) 01-14-2020  FDA Drug Safety Communication The U.S. Food and Drug Administration (FDA) is alerting the public that results […]

FDA identified 10 cases of constipation that progressed to serious complications with clozapine use reported in the FDA Adverse Event Reporting System (FAERS) database from July […]